![logo](/logos/AB.PA.webp)
AB Science S.A.
EPA:AB.PA
1.03 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | AB Science S.A. |
Symbool | AB.PA |
Munteenheid | EUR |
Prijs | 0.998 |
Beurswaarde | 52,270,250 |
Dividendpercentage | 0% |
52-weken bereik | 0.88 - 4.465 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Alain Moussy MBA |
Website | https://www.ab-science.com |
An error occurred while fetching data.
Over AB Science S.A.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)